Related Experiment Video
Updated: Jan 24, 2026

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema.
L De Simone1,2, A Sangiovanni1, R Aldigeri3
1Ocular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
Interferon (IFN) alpha-2a effectively reduced macular edema and improved vision in patients with post-uveitic refractory macular edema (ME). This treatment was found to be safe and well-tolerated, with significant improvements observed up to 12 months.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Post-uveitic refractory macular edema (ME) presents a significant challenge in ophthalmic care.
- Limited effective treatment options exist for persistent ME following uveitis.
Purpose of the Study:
- To evaluate the efficacy and safety of interferon (IFN) alpha-2a for treating post-uveitic refractory ME.
- To assess the impact of IFN alpha-2a on central macular thickness (CMT) and best-corrected visual acuity (BCVA).
Main Methods:
- Retrospective cohort study of 37 patients with post-uveitic refractory ME.
- Subcutaneous IFN alpha-2a injections administered for a minimum of 3 months.
- Comparison of baseline CMT and BCVA with follow-up data up to 12 months.
Main Results:
- Significant reduction in CMT from 438 μm to 335 μm after 1 month (p < 0.0001), sustained up to 12 months (286 μm, p = 0.001).
- Improvement in BCVA by 0.26 logMAR at 12 months (p = 0.001).
- 14 recurrences and 7 instances of treatment side effects were noted, with no serious adverse events.
Conclusions:
- Interferon (IFN) alpha-2a demonstrates efficacy in treating post-uveitic refractory ME.
- The treatment is safe and well-tolerated, offering a viable therapeutic option.
- Sustained improvements in both anatomical and visual outcomes were observed.
More Related Videos
04:32Measuring Post-Stroke Cerebral Edema, Infarct Zone and Blood-Brain Barrier Breakdown in a Single Set of Rodent Brain Samples
Published on: October 23, 2020
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
Related Concept Videos
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers